NEW YORK, Aug. 13, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, announced today that the Company and its subsidiary, Progenitor Cell Therapy ("PCT"), will present at two conferences in August.